All episodes
The Intersection of MASH and Cardiometabolic Risk - Part 2
The Intersection of MASH and Cardiometabolic Risk - Part 1
Case #3: A 54-Year-Old South Asian Male with a History of Cardiac Percutaneous Intervention
Case #2: A 62-Year-Old Diabetic Woman with an LDL-C of 53 mg/dL
Case #1: A 34-Year-Old Woman with Severe Heterozygous Familial Hypercholesterolemia (HeFH)
The Importance of Sleep Disorders and Cardiometabolic Health
Resiliency & Professional Career Development
Depression and Cardiovascular Diseases in Women
The Value of Being Part of the Future Leaders Program and Attending a CMHC Event - Part II
The Value of Being Part of the Future Leaders Program and Attending a CMHC Event - Part I
Expert Perspectives on Available Digital Intervention for Diabetes Care
Significance of Digital Health in Reducing Cardiometabolic Risks
Which is Better, Pharmacotherapy or Bariatric Surgery to Manage Obesity?
Tips and Pearls for Management of Cardio-renal Risks in Patients
Looking Beyond LDL-C to Address ASCVD Risk
Digital Health Technologies for Cardiometabolic Health: Barriers and Perspectives
Comprehensive Management of Type 2 Diabetes: Tips and Pearls
Expert Perspectives: Recap of Important Updates in Cardiometabolic Medicine 2023
The Value of Attending a CMHC Meeting
Disparities in the Management of Type 2 Diabetes in Women
Obesity & Lifestyle in Women
Unique Cardiometabolic Risk Factors in Women
The Link Between Chronic Inflammatory Conditions and Cardiovascular Risk
Cardiorenal Risk Reduction in T2DM
Inflammation and Current Concepts in the Treatment of Hypertension
Inflammation in Heart Failure
Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum | Episode 3: A Patient with Sleep Apnea & Comorbidities
Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum | Episode 2: Sodium as a Driver of Cardiovascular and Cardiometabolic Risk
Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum | Episode 1: Sodium Loading in Narcolepsy
Lifestyle, Diet, Physical Activity, and Inflammation
Obesity, Inflammation, and Cardiovascular Risk
The Utility of CGM in Type 2 Diabetes: Episode 3: Practical Pearls for Integrating CGM in Patient Care
The Utility of CGM in Type 2 Diabetes: Episode 2: Guidelines, Patient Selection, and Access to CGM
The Utility of CGM in Type 2 Diabetes: Episode 1: The Rationale for CGM in Type 2 Diabetes
Accelerating Diversity, Equity, and Inclusion
Obesity in Type 2 Diabetes Series | Episode 3: Evolution of Obesity Treatments
Obesity in Type 2 Diabetes Series | Episode 2: How Much Can I Do in My Practice to Address Obesity
Obesity in Type 2 Diabetes Series | Episode 1: How to Initiate the Conversation About Obesity in Patients with Type 2 Diabetes
CKD Series Episode 5: New and Emerging Therapies and Approaches for CKD
CKD Series Episode 4: Implications of Non-steroidal MRAs for DKD
CKD Series Episode 3: Updated Approach to Managing CKD in Patients with T2DM
CKD Series Episode 2: Counseling Patients about CKD
CKD Series Episode 1: Identifying Patients at Risk for DKD Onset or Progression
Continuous Glucose Monitoring for Patients with Anne Peters, MD
Treatment for Obesity for Patients with Dr Wyatt
The Role of Tirzepatide in Managing Type 2 Diabetes with Anne Peters, MD
The Role of Toxins in the Development of Cardiometabolic Diseases with Joe E. Pizzorno, ND
Diabetes: The Questions You Need to be Asking Your Patients with Dr Trindade
Food as Fuel and Her New Cookbook with Linda Shiue, MD
Updated 2022 ADA Standards of Care with Anne Peters, MD
Can We Slow the Progression of Diabetes or Reverse It?
Perspectives and Emerging Developments in NAFLD and NASH with Kenneth Cusi, MD
The Latest Cardiometabolic Concepts with Dr. George Bakris, MD
Emerging Strategies in Cardiometabolic Medicine with Dr. Mark Houston, MD, MS, FACP, ABAARM
Looming Cardiometabolic Crisis: A Conversation about Race with Keith C. Ferdinand, MD, FACC, FAHA, FASPC, FNLA
Addressing Disparities in Obesity Management with Fatima Stanford, MD
Making Sense of the Latest Developments with Javed Butler, MD
The Evolving Spectrum of Chronic Kidney Disease Treatment with Matthew R. Weir, MD
Food as Medicine with Linda Shiue, MD
VTE: A Discussion on Screening, Prevention, and Transition of Care
COVID-19 and New-Onset Diabetes
Clinical Pearls for Individualizing T2DM Therapy with SGLT2 Inhibitors and GLP-1 RAs
Ethnic & Racial Disparities in Cardiometabolic Health
Interview with Adam DeVore, MD, MHS
Interview with Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA
Interview with Dr. Louis Aronne
Interview with Dr. Chip Lavie
Interview with Dr. Ahmed M. Soliman, MD
Interview with Dr. Jay H. Shubrook, DO, FACOFP, FAAFP
Sneak Peek of Spring 2021 Keynote: Call to Action - Addressing The Disproportionate Burden & Disparities with COVID-19
Interview with Dr. Harold Bays
Asian Pacific Heritage Month
COVID-19 and Obesity
COVID-19, Cardiac Injury, and Statin Therapy
COVID-19 and Cardiovascular Disease
The Use of ACE inhibitors and Angiotensin Receptor Blockers in Patients with COVID-19
The impact of COVID-19 in Patients with Diabetes